Why the study?
Cerebral thromboembolism is a feared complication of transcatheter ablation in AF, and it was unclear which pre-procedural anticoagulation strategy results in less intracardiac activation of hemostasis during ablation.
Does uninterrupted dabigatran reduce intracardiac activation of hemostasis compared to vitamin K antagonists in patients with atrial fibrillation undergoing cryoballoon catheter ablation?
Does uninterrupted dabigatran reduce intracardiac activation of hemostasis compared to vitamin K antagonists in patients with atrial fibrillation undergoing cryoballoon catheter ablation?
Uninterrupted dabigatran provides greater inhibition of intracardiac hemostasis activation compared to VKAs during cryoballoon ablation for atrial fibrillation.
Answers are grounded in this paper and cite their sources.
Suggests dabigatran may better inhibit intracardiac hemostasis during ablation; hypothesis-generating and should not change practice pending larger trials.
BACKGROUND: Cerebral thromboembolism is a rare but feared complication of transcatheter ablation in patients with atrial fibrillation (AF). Here, we aimed to test which pre-procedural anticoagulation strategy results in less intracardiac activation of hemostasis during ablation. PATIENTS AND METHODS: = 17). Blood was drawn from the left atrium before and immediately after the ablation procedure. Cryoablations were performed according to standard protocols, during which heparin was administered. Heparin-insensitive markers of hemostasis and endothelial damage were tested from intracardiac samples: D-dimer, quantitative fibrin monomer (FM), plasmin-antiplasmin complex (PAP), von Willebrand factor (VWF) antigen, chromogenic factor VIII (FVIII) activity. VWF antigen and FVIII activity increased similarly post-ablation in all groups, suggesting comparable procedure-related endothelial damage. CONCLUSION: Dabigatran provides greater inhibition against intracardiac activation of hemostasis as compared to VKAs during cryoballoon catheter ablation.
No takes yet. Share an insight, caveat, or question.
Bagoly et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: